Merck, GSK and Pfizer vaccines get a boost as CDC lifts two-week restriction on pandemic shots

As revenues for several Big Pharma players slumped to start the year, execs blamed part of the problem on the accelerating COVID-19 vaccine rollout. The CDC had recommended people don't get another shot within two weeks of their COVID-19 vaccine, hitting sales for key products.